The state Supreme Court has decided against taking up two hormone-replacement therapy cases involving the drug Prempro and whether it caused breast cancer, letting stand an $11.2 million verdict against Wyeth Pharmaceuticals in one and a defense verdict in favor of the drugmaker in another.
October 21, 2013 at 12:00 AM
1 minute read
The state Supreme Court has decided against taking up two hormone-replacement therapy cases involving the drug Prempro and whether it caused breast cancer, letting stand an $11.2 million verdict against Wyeth Pharmaceuticals in one and a defense verdict in favor of the drugmaker in another.
The justices denied allocatur in Barton v. Wyeth Pharmaceuticals and Henry v. Wyeth Pharmaceuticals on October 16.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
